IDT Australia has responded to federal government appeals and is capable and prepared to manufacture Covid-19 vaccines and treatments at its Melbourne factory as they become available.
The company already has quality and good manufacturing practice (cGMP) approved drug manufacturing facilities that could be repurposed or expanded quickly to make vaccines and treatments.
CEO David Sparling said: “IDT has already been involved in the government’s response during the initial phase of the Covid-19 crisis.
“IDT has made a submission to (the federal government’s) request for information because we want to continue to play a role in Australia’s Covid-19 response and we believe that the company is well placed to potentially assist with Covid-19 vaccine and treatment projects.”
IDT, formally known as Institute for Drug Technology, has active pharmaceutical ingredient and completed oral dose manufacturing capabilities.
It has capability in producing excipients which are included in pharmaceuticals to aid manufacturing processes and buffers which adjust the acidity or alkalinity of processes.
IDT has extensive facilities including clean rooms, sterile filling lines and tablet and capsule manufacturing equipment as well as deep scientific and analytical capabilities.
Picture: IDT Australia
Subscribe to our free @AuManufacturing newsletter here.